Kenneth Fernald

The waves of Biotechnological Innovation in Medicine : Interfirm Cooperation Effects and a Venture Capital Perspective

K. Fernald, Kenneth Fernald, 2015 .

Upscaling vaccine manufacturing capacity - key bottlenecks and lessons learned

L. H. van de Burgwal, J. J. Feddema, Kenneth Fernald, 2023, Vaccine.

Bridging a pharma-like innovation gap in medical nutrition

H. Commandeur, K. Fernald, E. Claassen, 2014 .

Biotechnology Commercialization Strategies: Risk and Return in Interfirm Cooperation

E. Pennings, K. Fernald, E. Claassen, 2015 .

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance

H. Commandeur, K. Fernald, H. Pennings, 2017, PloS one.

Limits of Biotechnological Innovation

K. J. Sibley, E. Claassen, T. Weenen, 2013 .